413 related articles for article (PubMed ID: 30361202)
21. Zoster vaccine live.
Kockler DR; McCarthy MW
Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
[TBL] [Abstract][Full Text] [Related]
22. A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
Miller G; Schaefer H; Yoder S; Miller R; Winokur P; Kotloff K; Klassen D; Wierzbicki M; Amegashie C; Edwards K
Transpl Infect Dis; 2018 Jun; 20(3):e12874. PubMed ID: 29512282
[TBL] [Abstract][Full Text] [Related]
23. Herpes Zoster Vaccines.
Harbecke R; Cohen JI; Oxman MN
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S429-S442. PubMed ID: 34590136
[TBL] [Abstract][Full Text] [Related]
24. The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine.
Dagnew AF; Klein NP; Hervé C; Kalema G; Di Paolo E; Peterson J; Salaun B; Schuind A
J Infect Dis; 2021 Oct; 224(7):1139-1146. PubMed ID: 32103273
[TBL] [Abstract][Full Text] [Related]
25. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
Lecrenier N; Beukelaers P; Colindres R; Curran D; De Kesel C; De Saegher JP; Didierlaurent AM; Ledent EY; Mols JF; Mrkvan T; Normand-Bayle M; Oostvogels L; Da Silva FT; Vassilev V; Vinals C; Brecx A
Expert Rev Vaccines; 2018 Jul; 17(7):619-634. PubMed ID: 30028651
[TBL] [Abstract][Full Text] [Related]
26. Zoster vaccine live (Oka/Merck).
Robinson DM; Perry CM
Drugs Aging; 2006; 23(6):525-31; discussion 532-3. PubMed ID: 16872235
[TBL] [Abstract][Full Text] [Related]
27. Vaccination for preventing postherpetic neuralgia.
Chen N; Li Q; Zhang Y; Zhou M; Zhou D; He L
Cochrane Database Syst Rev; 2011 Mar; (3):CD007795. PubMed ID: 21412911
[TBL] [Abstract][Full Text] [Related]
28. Safety of live attenuated varicella-zoster vaccine in patients with underlying illnesses compared with healthy adults: a prospective cohort study.
Ohfuji S; Ito K; Inoue M; Ishibashi M; Kumashiro H; Hirota Y; Kayano E; Ota N
BMC Infect Dis; 2019 Jan; 19(1):95. PubMed ID: 30691396
[TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age.
Chlibek R; Bayas JM; Collins H; de la Pinta ML; Ledent E; Mols JF; Heineman TC
J Infect Dis; 2013 Dec; 208(12):1953-61. PubMed ID: 23904292
[TBL] [Abstract][Full Text] [Related]
30. Vaccine profile of herpes zoster (HZ/su) subunit vaccine.
Cunningham AL; Heineman T
Expert Rev Vaccines; 2017 Jul; 16(7):1-10. PubMed ID: 28486850
[TBL] [Abstract][Full Text] [Related]
31. Review: Adjuvant recombinant subunit vaccine prevents herpes zoster more than live attenuated vaccine in adults ≥ 50 years.
Sacks HS
Ann Intern Med; 2019 Feb; 170(4):JC14. PubMed ID: 30776803
[No Abstract] [Full Text] [Related]
32. Review of the Persistence of Herpes Zoster Vaccine Efficacy in Clinical Trials.
Cook SJ; Flaherty DK
Clin Ther; 2015 Nov; 37(11):2388-97. PubMed ID: 26602282
[TBL] [Abstract][Full Text] [Related]
33. Herpes zoster prevention: A difficult problem to solve.
Esposito S; Principi N
Vaccine; 2018 Aug; 36(36):5442-5448. PubMed ID: 28784283
[TBL] [Abstract][Full Text] [Related]
34. Herpes Zoster and Its Prevention by Vaccination.
Johnson RW; Levin MJ
Interdiscip Top Gerontol Geriatr; 2020; 43():131-145. PubMed ID: 32305975
[TBL] [Abstract][Full Text] [Related]
35. Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
Winston DJ; Mullane KM; Cornely OA; Boeckh MJ; Brown JW; Pergam SA; Trociukas I; Žák P; Craig MD; Papanicolaou GA; Velez JD; Panse J; Hurtado K; Fernsler DA; Stek JE; Pang L; Su SC; Zhao Y; Chan ISF; Kaplan SS; Parrino J; Lee I; Popmihajlov Z; Annunziato PW; Arvin A;
Lancet; 2018 May; 391(10135):2116-2127. PubMed ID: 29856344
[TBL] [Abstract][Full Text] [Related]
36. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
Burke MS
J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
[TBL] [Abstract][Full Text] [Related]
37. Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review.
Chiyaka ET; Nghiem VT; Zhang L; Deshpande A; Mullen PD; Le P
Pharmacoeconomics; 2019 Feb; 37(2):169-200. PubMed ID: 30367401
[TBL] [Abstract][Full Text] [Related]
38. Herpes zoster vaccine live: A 10 year review of post-marketing safety experience.
Willis ED; Woodward M; Brown E; Popmihajlov Z; Saddier P; Annunziato PW; Halsey NA; Gershon AA
Vaccine; 2017 Dec; 35(52):7231-7239. PubMed ID: 29174682
[TBL] [Abstract][Full Text] [Related]
39. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Oxman MN; Levin MJ; Johnson GR; Schmader KE; Straus SE; Gelb LD; Arbeit RD; Simberkoff MS; Gershon AA; Davis LE; Weinberg A; Boardman KD; Williams HM; Zhang JH; Peduzzi PN; Beisel CE; Morrison VA; Guatelli JC; Brooks PA; Kauffman CA; Pachucki CT; Neuzil KM; Betts RF; Wright PF; Griffin MR; Brunell P; Soto NE; Marques AR; Keay SK; Goodman RP; Cotton DJ; Gnann JW; Loutit J; Holodniy M; Keitel WA; Crawford GE; Yeh SS; Lobo Z; Toney JF; Greenberg RN; Keller PM; Harbecke R; Hayward AR; Irwin MR; Kyriakides TC; Chan CY; Chan IS; Wang WW; Annunziato PW; Silber JL;
N Engl J Med; 2005 Jun; 352(22):2271-84. PubMed ID: 15930418
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial.
Godeaux O; Kovac M; Shu D; Grupping K; Campora L; Douha M; Heineman TC; Lal H
Hum Vaccin Immunother; 2017 May; 13(5):1051-1058. PubMed ID: 28068212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
